• FirefoxInstall the new Firefox »
  •  Dow Down 0.45% Nasdaq Down 0.49%

    Nymox Pharmaceutical Corporation (NYMX)

    -NasdaqCM
    0.64 Up 0.21(50.55%) Feb 27, 3:59PM EST
    Add to Portfolio
    Prev Close:0.43
    Open:0.43
    Bid:N/A
    Ask:0.74 x 2000
    1y Target Est:10.25
    Beta:0.41
    Next Earnings Date:N/A
    Day's Range:0.41 - 0.64
    52wk Range:0.33 - 5.83
    Volume:3,197,239
    Avg Vol (3m):322,665
    Market Cap:22.92M
    P/E (ttm):N/A
    EPS (ttm):-0.16
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NYMX

    Comparison

    Symbol% ChgMkt Cap
    NYMXUp 50.55%22.92M
    ABTDown 0.50%71.33B
    LHDown 1.19%10.41B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):4.82
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :N/A
    Quarterly EPS Est (Mar-14) :N/A
    Mean Recommendation*:1.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Nymox Pharmaceutical Corporation, a biopharmaceutical company, is engaged in the research and development of products for the aging population. It provides NicAlert and TobacAlert products that use urine or saliva to detect use of and exposure to ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback